The Global Stem Cell Therapy Market is set to witness a healthy growth rate of 20% by 2029. A favorable investment ...

Longevity Health Holdings, Inc. (Nasdaq: XAGE) (“XAGE,” the “Company,” “we” or “our”), a company dedicated to advancing human longevity and healthy aging through regenerative bio-aesthetics, ...

Investors now have three ASX-listed stem cell therapy companies to choose from – and we can thank sector big daddy Mesoblast ...

Model more closely replicates natural environment of the pancreas, which will be essential for studying diabetes and ...

Researchers at the Francis Crick Institute have developed a new stem cell model of the mature human amniotic sac, which ...

Longevity Health Holdings, Inc. (Nasdaq: XAGE) (“XAGE,” the “Company,” “we,” “us,” or “our”), a company focused on extending ...

Their findings were published in the Journal of Translational Medicine. "hDPSCs are a type of mesenchymal stem cell that have the ability to differentiate into either odontoblasts or osteoblasts ...

Until now, cells dividing by mitosis were thought to grow round and then split into two identical, spherical daughter cells.New research has found that some cells are isomorphic, meaning they retain ...

Eligible patients met the following criteria: (1) age between 18 and 60 years; (2) diagnosis of acute leukemia or failure to find an human leukocyte antigen ... CONSORT diagram. MSC, mesenchymal stem ...

The study, published Sep. 10 in Stem Cell Reports, used human induced pluripotent stem cells -- a type of stem cell that are equivalent to cells in early embryonic development that can develop ...

Transplanted human stem cells successfully repaired macular holes in monkey models of the disorder. This is according to a new study from researchers at the Center for Biosystems Dynamics Research ...